T

Transhuman Capital

1 employees

Transhuman Capital is a venture capital firm that invests in pharmaceuticals, medical devices, and other technologies.

Investor insights

Sectors invested in

Gene Therapy4
Health Care4
Life Science4
Biotechnology4

Funding rounds participated in

$100M sweet spot round size

Most of their 4 investments are in rounds between $80M and $100M

Basic info

Industry

venture capital and private equity principals

Date founded

2014

Investments made

K

Kriya Therapeutics raised $270M on May 16, 2022

Investors: Narya, Dexcel Pharma, QVT Financial LLP, Patient Square Capital, Foresite Capital, JDRF T1D Fund and Transhuman Capital

K

Kriya Therapeutics raised $100M on July 14, 2021

Investors: Narya, QVT Financial LLP, Dexcel Pharma, Foresite Capital, Woodline Partners LP, Patient Square Capital, JDRF T1D Fund and Transhuman Capital

K

Kriya Therapeutics raised $81M on May 12, 2020

Investors: Narya, Sahsen Ventures, LLC, Foresite Capital, Dexcel Pharma, Amplo, JDRF T1D Fund, QVT Financial LLP and Transhuman Capital

K

Kriya Therapeutics raised undisclosed on October 1, 2019

Investors: Transhuman Capital

FAQ